The ultimate goal of preclinical studies is to generate data that can be used to make conclusions about the potential effects of a new medicine on the human body and to properly proceed to clinical trials. In this interview, Marina N. Makarova, Doctor of Medical Sciences, Director of the RMC “HOME OF PHARMACY”, shares her views on conducting preclinical studies in Russia.
No takes yet. Share an insight, caveat, or question.
М. Н. Макарова (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: